Data for Encapsulation of copper phenanthroline within horse spleen apoferritin: characterisation, cytotoxic activity and ability to retain temozolomide
Description
In this work, we investigate the encapsulation of a Cu(II)-phenanthroline complex (Cu(phen)(NO3)2) within HSAFt, as a potential vector for the delivery of anticancer agents. We immobilise Cu(II) within the protein as a metal complex with 1,10-phenanthroline, to form HSAFt-Cu(phen) dense particles that can be stored for months at low temperature (-20 °C). We subsequently characterise HSAFt-Cu(phen) by drug release studies and cytotoxicity assays against colorectal cancer cells and glioblastoma multiforme cells. We also investigate whether the presence of Cu(phen) inside HSAFt can offer additional benefits for the encapsulation and antitumour activity of anticancer drugs such as temozolomide (TMZ).
External URI
Subjects
- Drug delivery systems
- Chemistry
- Pharmacology
- apoferritin, copper phenanthroline, drug encapsulation
- Physical sciences
- Physical sciences::Chemistry
- Subjects Allied to Medicine::Pharmacology, toxicology & pharmacy
- Q Science
- R Medicine::RS Pharmacy and materia medica
- Q Science::QD Chemistry
Divisions
- University of Nottingham, UK Campus
Deposit date
2024-03-27Data type
Files for the characterisation of encapsulation experiments and of cytotoxic activityFunders
- Biotechnology & biological Sciences Research Council
Grant number
- BB/M008770/1
Collection dates
- 2019-2022
Data collection method
Experimental lab work and analytical methods for protein characterisation and bioactivityResource languages
- en